Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02236013 |
Title | A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Astellas Pharma Global Development, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Site US10003 | Los Angeles | California | 90095 | United States | Details | |
Site US10013 | New Haven | Connecticut | 06520 | United States | Details | |
Site US10004 | Chicago | Illinois | 60611 | United States | Details | |
Site US10009 | Westwood | Kansas | 66205 | United States | Details | |
Site US10001 | Baltimore | Maryland | 21231 | United States | Details | |
Site US10002 | New York | New York | 10032 | United States | Details | |
Site US10014 | Cleveland | Ohio | 44106 | United States | Details | |
Site US10019 | Oklahoma City | Oklahoma | 73104 | United States | Details | |
Site US10006 | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Site US10010 | San Antonio | Texas | 78229 | United States | Details |